Mesyrel Chemical & Pharmaceutical Ltd. was established in 1966.In 1968 it was re-organized as Mesyrel Chemical Pharmaceutical Co., Ltd.. In 1990 Mesyrel's (Trazodone)Bio-equivalent studies were approved by the Health Department. In 1991 Mesyrel was licensed and included in the new monitoring drugs.In 1992 Befon (Baclofen) cattle-equivalent studies were approved. In 1993 Mesyrel exported to the mainland. In 1996 Forflow SR long-acting formulations of the pipeline was listed. In 1998 the monitoring drugs Bensau and Ichderm were listed. Bensau and Fisherman's pharmaceutical were in cooperation. In 1999 MuactionSR long-acting formulations of the pipeline was listed. The monitoring drugs such as Nimed,Apano, Musgud and Detosiv were listed in 2000,2001 and 2002.In 2003 it established the International Department. Acne patented E-do was first listed in Taiwan.
Headquarters
17F., No.277, Songren Rd., Xin Yi Dist
Taipei City; Taipei City;
Contact Details: Purchase the Lotus Pharmaceutical Co., Ltd. report to view the information.
Website: http://www.lotuspharm.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service